A novel nomogram based on the hematological prognosis risk scoring system can predict the overall survival of patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel nomogram based on the hematological prognosis risk scoring system can predict the overall survival of patients with hepatocellular carcinoma

Published:2023-08-16 Issue:16 Volume:149 Page:14631-14640
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Lei Kai,Deng Zhuofan,Wang Jiaguo,Wang Hongxiang,Hu Run,Li Yin,Wang Xingxing,Xu Jie,You Ke,Liu Zuojin

Funder

National Natural Science Foundation of China

Chongqing Medical University Program for Youth Innovation in Future Medicine

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05255-3.pdf

Reference30 articles.

1. Cao W et al (2021) Potentiality of alpha-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma. Bioengineered 12(2):9435–9451. https://doi.org/10.1080/21655979.2021.1990195

2. Chen JS et al (2012) Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis. J Surg Res 175(2):243–250. https://doi.org/10.1016/j.jss.2011.03.072

3. Chen L et al (2020) The research progress on the prognostic value of the common hematological parameters in peripheral venous blood in breast cancer. Onco Targets Ther 13:1397–1412. https://doi.org/10.2147/OTT.S227171

4. Chen KD et al (2021) The perioperatively altered neutrophil-to-lymphocyte ratio associates with impaired DNA damage response in liver transplantation recipients with hepatocellular carcinoma. Diagnostics (basel). https://doi.org/10.3390/diagnostics11020209

5. Ding X et al (2021) Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: a prospective randomized study. Cancer 127(20):3782–3793. https://doi.org/10.1002/cncr.33677

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of psoas muscle index in male hepatocellular carcinoma patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors;Human Vaccines & Immunotherapeutics;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3